期刊
VIRUSES-BASEL
卷 14, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/v14071493
关键词
viruses; T-cells; immunity; biomarkers; virotherapy
类别
资金
- Cancer Research UK (CRUK) [C25574/A24321]
- European Union [777682]
The number of emerging and re-emerging viral diseases has increased globally in recent decades. Host factors such as age, ethnicity, and underlying pathologies can affect the immune response and the outcome following viral infection.
Emerging and re-emerging viral diseases have increased in number and geographical extent during the last decades. Examples include the current COVID-19 pandemic and the recent epidemics of the Chikungunya, Ebola, and Zika viruses. Immune responses to viruses have been well-characterised within the innate and adaptive immunity pathways with the outcome following viral infection predominantly attributed to properties of the virus and circumstances of the infection. Perhaps the belief that the immune system is often considered as a reactive component of host defence, springing into action when a threat is detected, has contributed to a poorer understanding of the inherent differences in an individual's immune system in the absence of any pathology. In this review, we focus on how these host factors (age, ethnicity, underlying pathologies) may skew the T helper cell response, thereby influencing the outcome following viral infection but also whether we can use these inherent biases to predict patients at risk of a deviant response and apply strategies to avoid or overcome them.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据